<?xml version="1.0" encoding="UTF-8"?>
<p id="par0060">“Dataset_112” included 112 genomes of SARS-CoV-2 strains sampled from Australia (
 <italic>n</italic> = 8), Belgium (
 <italic>n</italic> = 1), China (Chongqing, 
 <italic>n</italic> = 3; Fujian Province, 
 <italic>n</italic> = 2; Guangdong Province, 
 <italic>n</italic> = 16; Hubei Province, 
 <italic>n</italic> = 21; Jiangsu Province, 
 <italic>n</italic> = 1; Jiangxi Province, 
 <italic>n</italic> = 1; Sichuan Province, 
 <italic>n</italic> = 1; Taiwan, 
 <italic>n</italic> = 3; Yunnan Province, 
 <italic>n</italic> = 1; and Zhejiang Province, 
 <italic>n</italic> = 4), Finland (
 <italic>n</italic> = 1), France (
 <italic>n</italic> = 10), Germany (
 <italic>n</italic> = 1), Japan (
 <italic>n</italic> = 7), Korea (
 <italic>n</italic> = 1), Nepal (
 <italic>n</italic> = 1), Singapore (
 <italic>n</italic> = 11), Thailand (
 <italic>n</italic> = 2), UK (
 <italic>n</italic> = 2), and USA (
 <italic>n</italic> = 14) with sampling dates between 24 December 2019 and 9 February 2020 (Supplementary Table 1). The samples were primarily from China (53/112, 47.32 %) and Hubei Province (21/112, 18.75 %), the Chinese Province acknowledged as the original epicenter of the SARS-CoV-2 outbreak.
</p>
